Spirocyclic ureas: Orally bioavailable 11β-HSD1 inhibitors identified by computer-aided drug design
Graphical abstract
References and notes (40)
- et al.
Drug Discovery Today
(2007) - et al.
Best Pract. Res., Clin. Endocrinol. Metab.
(2007) - et al.
J. Biol. Chem.
(2001) - et al.
Bioorg. Med. Chem. Lett.
(2007) - et al.
Bioorg. Med. Chem. Lett.
(2008) - et al.
Bioorg. Med. Chem. Lett.
(2008) - et al.
Bioorg. Med. Chem. Lett.
(2005) - et al.
Bioorg. Med. Chem. Lett.
(2009) - et al.
J. Med. Chem.
(2008) Curr. Med. Chem.
(2008)
Ann. N.Y. Acad. Sci.
Science (Washington, DC, U. S.)
J. Clin. Invest.
Proc. Natl. Acad. Sci. U.S.A.
Diabetes
J. Clin. Endocrinol. Metab.
Diabetes
J. Med. Chem.
Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)
Curr. Opin. Drug Disc. Dev.
Cited by (23)
Accelerated skin wound healing by selective 11β-Hydroxylase (CYP11B1) inhibitors
2018, European Journal of Medicinal ChemistryCitation Excerpt :Another study in mice skin showed an increase of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1, reduces 11-dehydrocorticosterone to corticosterone in rodents) expression, but a lack of CYP11B1 expression during wound healing [10]. Blockade of 11β-HSD1 by subcutaneous application of the inhibitor 2 (IC50 11β-HSD1 = 1.1 nM, Fig. 2) [13] resulted in enhanced wound healing in mice (in vivo) [14]. In fact, 1 is a non-selective inhibitor of CYP enzymes [15] and, in our studies, inhibits 11β-HSD1 (54% at 50 μM and 70% at 200 μM, Fig. 2) as well.
Virtual screening applications in short-chain dehydrogenase/reductase research
2017, Journal of Steroid Biochemistry and Molecular BiologyCitation Excerpt :A number of adamantine-containing selective 11β-HSD1 inhibitors have been reported [96]. Tice et al. used them to generate models of the 11β-HSD1 binding site with the help of a proprietary structure-based drug design program of Vitae Pharmaceuticals called Contour [97]. The most satisfactory poses were selected, and based on them a medicinal chemistry program was initiated to improve potency, selectivity, and physical properties, supported by additional modeling.
Chromatography-free stereoselective synthesis of (R)-3-benzylpiperidine
2016, Tetrahedron LettersCitation Excerpt :However, due to their nature, each of the established stereoselective methods has certain limits in substrate scope and a complementary stereoselective synthetic route toward varied 3-benzylpiperidines might be of high value. 3-Acylacrylic acids have proven to be very good substrates for crystallization-induced asymmetric transformations (CIAT), yielding a variety of functionalized α-amino acids in excellent yields and stereoselectivities.11–13 We envisioned that 4-aroylpent-4-enoic acids 9 in conjunction with aza-Michael additions might be utilized in a similar fashion, since they have structural features characteristic for known successful CIAT systems (Scheme 1).
Searching for novel applications of the benzohomoadamantane scaffold in medicinal chemistry: Synthesis of novel 11β-HSD1 inhibitors
2015, Bioorganic and Medicinal ChemistryNovel 11β-HSD1 inhibitors: C-1 versus C-2 substitution and effect of the introduction of an oxygen atom in the adamantane scaffold
2015, Bioorganic and Medicinal Chemistry LettersThe use of spirocyclic scaffolds in drug discovery
2014, Bioorganic and Medicinal Chemistry Letters